1DROP Diagnostics, a Neuchâtel-based start-up dedicated to enabling precision medicine through non-invasive diagnostic tests, developed 1DROP a portable medical diagnostics device currently capable of detecting biomarkers of cardiovascular health, liver and kidney function from a single drop of a sample with laboratory quality results.
The start-up has announced its partnership with the International Space Station U.S. National Laboratory (ISS National Lab) managed by the Center for the Advancement of Science in Space (CASIS), to collaborate on lab on a chip technology for medical diagnostics on the International Space Station.
This mission will demonstrate capillary flow control in microstructures, particle focusing, plasma separation, and will be quantified using fluorescent biochemical reactions. SpaceX’s 20th commercial resupply service mission carried 1DROP devices to the International Space Station.
"The ISS and space are the ultimate remote setting to demonstrate medical diagnostics. If 1DROP is suited to assess the health of astronauts in space, it's suited to assess people’s health everywhere on earth. We are also currently developing 1DROP for long-duration space missions to Mars", commented Luc Gervais, Founder and CEO of 1DROP.
Headquartered in Neuchâtel at the Microcity Innovation Pole and with an office in Boston, 1Drop provides innovative diagnostic solutions for multiplexed assays of proteins, nucleic acids and peptides serve as tools for the development of new therapies, disease research, and clinical diagnostic tests.
